These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 33288560)
1. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue. Nakagawa N; Tanaka K; Sonohara F; Kandimalla R; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y Anticancer Res; 2020 Dec; 40(12):6665-6676. PubMed ID: 33288560 [TBL] [Abstract][Full Text] [Related]
2. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918 [TBL] [Abstract][Full Text] [Related]
3. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma. Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222 [TBL] [Abstract][Full Text] [Related]
4. m Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584 [TBL] [Abstract][Full Text] [Related]
5. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis. Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124 [TBL] [Abstract][Full Text] [Related]
6. The RNA Demethylases ALKBH5 and FTO Regulate the Translation of ATF4 mRNA in Sorafenib-Treated Hepatocarcinoma Cells. Adjibade P; Di-Marco S; Gallouzi IE; Mazroui R Biomolecules; 2024 Aug; 14(8):. PubMed ID: 39199320 [TBL] [Abstract][Full Text] [Related]
7. Demethylases in tumors and the tumor microenvironment: Key modifiers of N Guo J; Zhao L; Duan M; Yang Z; Zhao H; Liu B; Wang Y; Deng L; Wang C; Jiang X; Jiang X Biomed Pharmacother; 2024 May; 174():116479. PubMed ID: 38537580 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus-Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape. Meng Y; Shu Z; Wang X; Hong L; Wang B; Jiang J; He K; Cao Q; Shi F; Wang H; Gong L; Diao H Mol Cancer Res; 2024 Jul; 22(7):642-655. PubMed ID: 38546386 [TBL] [Abstract][Full Text] [Related]
9. Increased N6-methyladenosine causes infertility is associated with FTO expression. Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212 [TBL] [Abstract][Full Text] [Related]
11. SIRT1 Regulates N Liu X; Liu J; Xiao W; Zeng Q; Bo H; Zhu Y; Gong L; He D; Xing X; Li R; Zhou M; Xiong W; Zhou Y; Zhou J; Li X; Guo F; Xu C; Chen X; Wang X; Wang F; Wang Q; Cao K Hepatology; 2020 Dec; 72(6):2029-2050. PubMed ID: 32154934 [TBL] [Abstract][Full Text] [Related]
12. Distinct RNA Toh JDW; Crossley SWM; Bruemmer KJ; Ge EJ; He D; Iovan DA; Chang CJ Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25284-25292. PubMed ID: 32989163 [TBL] [Abstract][Full Text] [Related]
13. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers. He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919 [TBL] [Abstract][Full Text] [Related]
14. m Takemoto S; Nakano M; Fukami T; Nakajima M Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357 [TBL] [Abstract][Full Text] [Related]
15. N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5. Zou S; Toh JD; Wong KH; Gao YG; Hong W; Woon EC Sci Rep; 2016 May; 6():25677. PubMed ID: 27156733 [TBL] [Abstract][Full Text] [Related]
16. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2. Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133 [TBL] [Abstract][Full Text] [Related]
17. Chang Q; Zhou X; Mao H; Feng J; Wu X; Zhang Z; Hu Z Biomol Biomed; 2024 Sep; 24(5):1216-1230. PubMed ID: 38501918 [TBL] [Abstract][Full Text] [Related]
18. Identification of Flavin Mononucleotide as a Cell-Active Artificial N Xie LJ; Yang XT; Wang RL; Cheng HP; Li ZY; Liu L; Mao L; Wang M; Cheng L Angew Chem Int Ed Engl; 2019 Apr; 58(15):5028-5032. PubMed ID: 30756480 [TBL] [Abstract][Full Text] [Related]
19. FTO, m Mauer J; Jaffrey SR FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392 [TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization. Liu J; Wang D; Zhou J; Wang L; Zhang N; Zhou L; Zeng J; Liu J; Yang M Arch Toxicol; 2021 May; 95(5):1621-1629. PubMed ID: 33713148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]